| Document Date: 2014-08-16 15:09:08
Open Document File Size: 64,43 KBShare Result on Facebook
City Nicotiana / Toronto / Owensboro / / Company Mapp / Ebola / Icon Genetics AG / / Country Germany / United States / / Event Business Partnership / / IndustryTerm plug-andplay antibody manufacturing process / multipurpose prevention technology / experimental product / manufacturing / antibody products / excellent public health tools / / MedicalCondition HIV / disease / malaria / Ebola / relatively recently discovered disease / e.g. cancer / infectious exposure / inflammatory molecules / infectious pathogen / diseases / Equine encephalitis viruses / AIDS / infection / infectious disease / sexually transmitted diseases / / MedicalTreatment antibody therapy / / Organization Public Health Agency of Canada / U.S. government / FDA / / Product nicotine / / Technology multipurpose prevention technology / biopharmaceuticals / antibodies / BioProcessing / /
SocialTag |
Does ZMappTM work? We don’t know. The ZMappTM combination of antibodies was identified in January[removed]As an experimental product only limited supplies were manufactured for testing in animals. ZMappTM has shown effic